You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 14, 2024

Rvl Pharms Company Profile

✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for RVL PHARMS, and what generic alternatives to RVL PHARMS drugs are available?

RVL PHARMS has one approved drug.

There are twelve US patents protecting RVL PHARMS drugs.

There are forty-six patent family members on RVL PHARMS drugs in twenty-eight countries.

Summary for Rvl Pharms

International Patents:	46
US Patents:	12
Tradenames:	1
Ingredients:	1
NDAs:	1

Drugs and US Patents for Rvl Pharms

+ Get email alerts for changes to this table

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Rvl Pharms	UPNEEQ	oxymetazoline hydrochloride	SOLUTION/DROPS;OPHTHALMIC	212520-001	Jul 8, 2020		RX	Yes	Yes	11,541,036	⤷ Sign Up	Y			⤷ Sign Up
Rvl Pharms	UPNEEQ	oxymetazoline hydrochloride	SOLUTION/DROPS;OPHTHALMIC	212520-001	Jul 8, 2020		RX	Yes	Yes	10,898,573	⤷ Sign Up	Y			⤷ Sign Up
Rvl Pharms	UPNEEQ	oxymetazoline hydrochloride	SOLUTION/DROPS;OPHTHALMIC	212520-001	Jul 8, 2020		RX	Yes	Yes	11,324,722	⤷ Sign Up				⤷ Sign Up
Rvl Pharms	UPNEEQ	oxymetazoline hydrochloride	SOLUTION/DROPS;OPHTHALMIC	212520-001	Jul 8, 2020		RX	Yes	Yes	11,311,515	⤷ Sign Up	Y			⤷ Sign Up
Rvl Pharms	UPNEEQ	oxymetazoline hydrochloride	SOLUTION/DROPS;OPHTHALMIC	212520-001	Jul 8, 2020		RX	Yes	Yes	10,912,765	⤷ Sign Up				⤷ Sign Up
Rvl Pharms	UPNEEQ	oxymetazoline hydrochloride	SOLUTION/DROPS;OPHTHALMIC	212520-001	Jul 8, 2020		RX	Yes	Yes	9,867,808	⤷ Sign Up				⤷ Sign Up
Rvl Pharms	UPNEEQ	oxymetazoline hydrochloride	SOLUTION/DROPS;OPHTHALMIC	212520-001	Jul 8, 2020		RX	Yes	Yes	10,799,481	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

International Patents for Rvl Pharms Drugs

Subscribe to access the full database, or Sign Up
Country	Patent Number	Estimated Expiration
Japan	7141420	⤷ Sign Up
South Korea	20200128629	⤷ Sign Up
Canada	2827285	⤷ Sign Up
Japan	2020183373	⤷ Sign Up
Slovenia	2680829	⤷ Sign Up
Japan	2014506927	⤷ Sign Up
Australia	2012223615	⤷ Sign Up
>Country	>Patent Number	>Estimated Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Rvl Pharms

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.